Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01330940 · ClinicalTrials.gov registry record · NA
Effect of Diet Orange Soda on Urinary Lithogenicity
A NA study of Nephrolithiasis and Kidney Stones, sponsored by VA New York Harbor Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT01330940: Completed NA study of Nephrolithiasis and Kidney Stones, sponsored by VA New York Harbor Healthcare System.
NCT01330940 is a NA study of Nephrolithiasis and Kidney Stones that has completed, run by VA New York Harbor Healthcare System. The registered enrollment target is 12 participants, below the 124-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01330940, a NA study of Nephrolithiasis and Kidney Stones, has completed, sponsored by VA New York Harbor Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
Beverages containing citrate may be useful in increasing urine citrate content and urine pH. Such changes in urine chemistry could help prevent kidney stones. Diet orange soda has more citrate than other similar beverages. The investigators are interested in whether diet soda will improve urine chemistry in the appropriate manner.
Primary Outcome
Citrate is measured in 24h urine sample and expressed as mg/day
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Orange soda
Study Locations (1)
New York
- New York Harbor VA Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-07 |
| Phase | NA |
What the finished NCT01330940 record still lists
NCT01330940 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 124-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (90% lower).
The record links to 3 conditions, with Nephrolithiasis appearing as the primary indexed condition, and to 1 intervention - of which Orange soda is the first listed.
NCT01330940 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01330940 about?
NCT01330940 is a clinical study titled "Effect of Diet Orange Soda on Urinary Lithogenicity". Beverages containing citrate may be useful in increasing urine citrate content and urine pH. Such changes in urine chemistry could help prevent kidney stones. Diet orange soda has more citrate than other similar beverages. The investigators are interested in whether diet soda will improve urine chem...
What is the current status of trial NCT01330940?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2009-11. Estimated completion is 2010-07.
What conditions does trial NCT01330940 study?
This clinical trial studies the following conditions: Nephrolithiasis, Kidney Stones, Urolithiasis.
What interventions are being tested in trial NCT01330940?
The interventions under investigation include: Orange soda (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01330940?
This trial is sponsored by VA New York Harbor Healthcare System, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01330940 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nephrolithiasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01330940's enrollment target sits among peer trials
12 17th of 16 the lowest of 16 other Nephrolithiasis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nephrolithiasis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
-
Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)
RECRUITING · NA
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
RECRUITING · NA
-
Evaluation of Genetic Abnormalities Amongst Calcium Phosphate Stone Formers
RECRUITING · NA
-
Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia